Concepedia
Statistics
Publications
9
Citations
864
H-Index
Active since
2002
Affiliations
Pfizer (United States)(Current)
Princeton University
University of North Carolina at Chapel Hill
Sarah K. Leonard is an author at Pfizer (United States) specializing in pharmacology, neuroscience, and neuropharmacology.
Publications per year
2002–2012
The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimer's disease
David Riddell, Hua Zhou, Thomas A. Comery et al. · Molecular and Cellular Neuroscience · 2007 · 248 citations
Life Sciences, Neuroscience, Pharmacology +16
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist
Robert H. Ring, Lee E. Schechter, Sarah K. Leonard et al. · Neuropharmacology · 2009 · 145 citations
Medicine, Neuroscience, Pharmacology +10
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders
Sarah K. Leonard, Jason M. Dwyer, Stacey J. Sukoff Rizzo et al. · Psychopharmacology · 2008 · 139 citations
Medicine, Neuroscience, Pharmacology +16
The Metabotropic Glutamate Receptor 7 Allosteric Modulator AMN082: A Monoaminergic Agent in Disguise?
Stacey J. Sukoff Rizzo, Sarah K. Leonard, A. Gilbert et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 104 citations
Medicine, Neuroscience, Pharmacology +12
Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression
Zoë A. Hughes, Daniel L. Smith, Stacey J. Sukoff Rizzo et al. · Neuropharmacology · 2012 · 85 citations
Medicine, Neuroscience, Pharmacology +17
1–5 of 9